Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Mantle Cell Lymphoma Therapeutics Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Combination Therapy
  • 1.4.3 Monotherapy
• 1.5 Market by Application
  • 1.5.1 Global Mantle Cell Lymphoma Therapeutics Market Share by Application (2019-2025)
  • 1.5.2 Hospital
  • 1.5.3 Research Institute
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Mantle Cell Lymphoma Therapeutics Market Size
• 2.2 Mantle Cell Lymphoma Therapeutics Growth Trends by Regions
  • 2.2.1 Mantle Cell Lymphoma Therapeutics Market Size by Regions (2019-2025)
  • 2.2.2 Mantle Cell Lymphoma Therapeutics Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Mantle Cell Lymphoma Therapeutics Market Size by by Players
  • 3.1.1 Global Mantle Cell Lymphoma Therapeutics Revenue by by Players (2014-2019)
  • 3.1.2 Global Mantle Cell Lymphoma Therapeutics Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Mantle Cell Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.2 Mantle Cell Lymphoma Therapeutics Key Players Head office and Area Served
• 3.3 Key Players Mantle Cell Lymphoma Therapeutics Product/Solution/Service
• 3.4 Date of Enter into Mantle Cell Lymphoma Therapeutics Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Mantle Cell Lymphoma Therapeutics Market Size by Type (2014-2019)
• 4.2 Global Mantle Cell Lymphoma Therapeutics Market Size by Application (2014-2019)

5 North America

• 5.1 North America Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
• 5.2 Mantle Cell Lymphoma Therapeutics Key Players in North America
• 5.3 North America Mantle Cell Lymphoma Therapeutics Market Size by Type
• 5.4 North America Mantle Cell Lymphoma Therapeutics Market Size by Application

6 Europe

• 6.1 Europe Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
• 6.2 Mantle Cell Lymphoma Therapeutics Key Players in Europe
• 6.3 Europe Mantle Cell Lymphoma Therapeutics Market Size by Type
• 6.4 Europe Mantle Cell Lymphoma Therapeutics Market Size by Application

7 China

• 7.1 China Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
• 7.2 Mantle Cell Lymphoma Therapeutics Key Players in China
• 7.3 China Mantle Cell Lymphoma Therapeutics Market Size by Type
• 7.4 China Mantle Cell Lymphoma Therapeutics Market Size by Application

8 Japan

• 8.1 Japan Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
• 8.2 Mantle Cell Lymphoma Therapeutics Key Players in Japan
• 8.3 Japan Mantle Cell Lymphoma Therapeutics Market Size by Type
• 8.4 Japan Mantle Cell Lymphoma Therapeutics Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
• 9.2 Mantle Cell Lymphoma Therapeutics Key Players in Southeast Asia
• 9.3 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Type
• 9.4 Southeast Asia Mantle Cell Lymphoma Therapeutics Market Size by Application

10 India

• 10.1 India Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
• 10.2 Mantle Cell Lymphoma Therapeutics Key Players in India
• 10.3 India Mantle Cell Lymphoma Therapeutics Market Size by Type
• 10.4 India Mantle Cell Lymphoma Therapeutics Market Size by Application

11 Central & South America

• 11.1 Central & South America Mantle Cell Lymphoma Therapeutics Market Size (2014-2019)
• 11.2 Mantle Cell Lymphoma Therapeutics Key Players in Central & South America
• 11.3 Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Type
• 11.4 Central & South America Mantle Cell Lymphoma Therapeutics Market Size by Application

12 International Players Profiles

• 12.1 Allergan Plc
  • 12.1.1 Allergan Plc Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Mantle Cell Lymphoma Therapeutics Introduction
  • 12.1.4 Allergan Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019))
  • 12.1.5 Allergan Plc Recent Development
• 12.2 AstraZeneca Plc
  • 12.2.1 AstraZeneca Plc Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Mantle Cell Lymphoma Therapeutics Introduction
  • 12.2.4 AstraZeneca Plc Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
  • 12.2.5 AstraZeneca Plc Recent Development
• 12.3 Celgene Corp.
  • 12.3.1 Celgene Corp. Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Mantle Cell Lymphoma Therapeutics Introduction
  • 12.3.4 Celgene Corp. Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
  • 12.3.5 Celgene Corp. Recent Development
• 12.4 Johnson & Johnson Services Inc.
  • 12.4.1 Johnson & Johnson Services Inc. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Mantle Cell Lymphoma Therapeutics Introduction
  • 12.4.4 Johnson & Johnson Services Inc. Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
  • 12.4.5 Johnson & Johnson Services Inc. Recent Development
• 12.5 Takeda Pharmaceutical Co. Ltd.
  • 12.5.1 Takeda Pharmaceutical Co. Ltd. Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Mantle Cell Lymphoma Therapeutics Introduction
  • 12.5.4 Takeda Pharmaceutical Co. Ltd. Revenue in Mantle Cell Lymphoma Therapeutics Business (2014-2019)
  • 12.5.5 Takeda Pharmaceutical Co. Ltd. Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.
Nonetheless, progress in the clinical use of mAbs is hindered by poor efficacy, off-target toxicities and drug resistance. Thus, novel mAbs engineering and approaches to improve target specificity and enhance affinity and potency are required.
In 2018, the global Mantle Cell Lymphoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Mantle Cell Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mantle Cell Lymphoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Allergan Plc
AstraZeneca Plc
Celgene Corp.
Johnson & Johnson Services Inc.
Takeda Pharmaceutical Co. Ltd.
...

Market segment by Type, the product can be split into
Combination Therapy
Monotherapy

Market segment by Application, split into
Hospital
Research Institute
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Mantle Cell Lymphoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Mantle Cell Lymphoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Mantle Cell Lymphoma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.